Open Label, Multicenter, Trial to Evaluate Safety, Tolerability and Efficacy of Tocilizumab in Monotherapy or in Combination With MTX in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non Biologic DMARDs.
Phase of Trial: Phase III
Latest Information Update: 23 May 2013
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 19 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2012 Planned End Date changed from 1 Jul 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.